Table 4 Proportion of patients developing metastases in relation to Breslow group of the melanoma and A-1012G genotype

From: A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma

 

Breslow thickness group

 

In situ

<0.75 mm

0.75–1.49 mm

1.5–3.49 mm

⩾3.5 mm

GG

0% (0/3)

0% (0/5)

0% (0/3)

0% (0/4)

0% (0/2)

AG

0% (0/13)

0% (0/30)

0% (0/17)

17% (3/18)

27% (4/15)

AA

0% (0/7)

8% (1/13)

12% (2/16)

14% (2/14)

67% (6/9)

  1. ()=number of patients developing metastasis/total number patients in each group.
Back to article page